SATURN

Impact of Specific Antibiotic Therapies on the prevalence of hUman host ResistaNt bacteria

 Coordinatore UNIVERSITE DE GENEVE 

 Organization address address: Rue du General Dufour 24
city: GENEVE
postcode: 1211

contact info
Titolo: Dr.
Nome: Stephan Jurgen
Cognome: Harbarth
Email: send email
Telefono: 41223723357
Fax: 41223723987

 Nazionalità Coordinatore Switzerland [CH]
 Totale costo 7˙821˙538 €
 EC contributo 5˙999˙436 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2009-single-stage
 Funding Scheme CP-FP
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-01-01   -   2014-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITE DE GENEVE

 Organization address address: Rue du General Dufour 24
city: GENEVE
postcode: 1211

contact info
Titolo: Dr.
Nome: Stephan Jurgen
Cognome: Harbarth
Email: send email
Telefono: 41223723357
Fax: 41223723987

CH (GENEVE) coordinator 684˙400.00
2    UNIVERSITEIT ANTWERPEN

 Organization address address: PRINSSTRAAT 13
city: ANTWERPEN
postcode: 2000

contact info
Titolo: Ms.
Nome: Anne
Cognome: Adams
Email: send email
Telefono: +32 3 2653028
Fax: +32 3 2653011

BE (ANTWERPEN) participant 1˙017˙911.00
3    THE FOUNDATION FOR MEDICAL RESEARCHINFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV

 Organization address address: WEIZMANN STREET 6
city: Tel Aviv
postcode: 64239

contact info
Titolo: Dr.
Nome: Michal
Cognome: Roll
Email: send email
Telefono: +972 36974761
Fax: +972 36925739

IL (Tel Aviv) participant 922˙947.00
4    UNIVERSITAIR MEDISCH CENTRUM UTRECHT

 Organization address address: HEIDELBERGLAAN 100
city: UTRECHT
postcode: 3584 CX

contact info
Titolo: Prof.
Nome: Anne-Marie
Cognome: Laeven
Email: send email
Telefono: +31 887568181
Fax: +31 887568099

NL (UTRECHT) participant 806˙190.00
5    UNIVERSITA CATTOLICA DEL SACRO CUORE

 Organization address address: Largo Agostino Gemelli 1
city: MILANO
postcode: 20123

contact info
Titolo: Mr.
Nome: Filippo
Cognome: Leone
Email: send email
Telefono: +39 06 30156099
Fax: +39 06 30156803

IT (MILANO) participant 592˙349.60
6    ARTTIC

 Organization address address: Rue du Dessous des Berges 58A
city: PARIS
postcode: 75013

contact info
Titolo: Dr.
Nome: Eric
Cognome: Papon
Email: send email
Telefono: +33 153945460
Fax: +33 153945470

FR (PARIS) participant 374˙041.30
7    STICHTING KATHOLIEKE UNIVERSITEIT

 Organization address address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ

contact info
Titolo: Dr.
Nome: Johan Willem
Cognome: Mouton
Email: send email
Telefono: +31 24 361 4356
Fax: +31 24 356 4606

NL (NIJMEGEN) participant 373˙549.00
8    CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

 Organization address address: CALLE ROSSELLO 149 PUERTA BJS
city: BARCELONA
postcode: 8036

contact info
Titolo: Prof.
Nome: Ramon
Cognome: Gomis
Email: send email
Telefono: 34932279884
Fax: 34932279205

ES (BARCELONA) participant 267˙567.80
9    ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

 Organization address address: 3 Avenue Victoria
city: PARIS
postcode: 75004

contact info
Titolo: Mr.
Nome: Christophe
Cognome: Misse
Email: send email
Telefono: +33 1 40 27 46 13

FR (PARIS) participant 235˙389.74
10    JULIUS-MAXIMILIANS UNIVERSITAET WUERZBURG

 Organization address address: SANDERRING 2
city: WUERZBURG
postcode: 97070

contact info
Titolo: Mr.
Nome: Christian
Cognome: Gloggengiesser
Email: send email
Telefono: +49 931312294
Fax: +49 9318887180

DE (WUERZBURG) participant 212˙987.00
11    UNIVERSYTET MEDYCZNY W LODZI.

 Organization address address: Al. Kosciuszki, 4
city: LODZ
postcode: 90419

contact info
Titolo: Dr.
Nome: Maciej
Cognome: Godycki-Cwirko
Email: send email
Telefono: +48 42 679 55 46
Fax: +48 42 678 60 41

PL (LODZ) participant 178˙761.80
12    INSTITUTE FOR INFECTIOUS DISEASES PROF DR. MATEI BALS

 Organization address address: Street Dr. C. Grozovici 1 1
city: Bucharest
postcode: 21105

contact info
Titolo: Ms.
Nome: Daniela
Cognome: Dumitrascu
Email: send email
Telefono: +40 721614981

RO (Bucharest) participant 145˙975.00
13    Clinical Center of Serbia

 Organization address address: Pasterova 2
city: Belgrade
postcode: 11000

contact info
Titolo: Dr.
Nome: Zivan
Cognome: Maksimovic
Email: send email
Telefono: +381 11 2644850
Fax: +381 11 3067198

RS (Belgrade) participant 145˙103.30
14    EBERHARD KARLS UNIVERSITAET TUEBINGEN

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Prof.
Nome: Evelina
Cognome: Tacconelli
Email: send email
Telefono: +49 7071 29 85020
Fax: +49 7071 29 25074

DE (TUEBINGEN) participant 34˙811.60
15    Fondation hopital Saint Joseph

 Organization address address: Rue Raymond Losserand 185
city: Paris
postcode: 75674

contact info
Titolo: Mr.
Nome: Philippe
Cognome: Fradin
Email: send email
Telefono: 33144123482
Fax: 33144123870

FR (Paris) participant 7˙451.86
16    STICHTING NIJMEEGS INTERCONFESSIONEEL ZIEKENHUIS CANISIUS WILHELMINA

 Organization address address: WEG DOOR JONKERBOS 100
city: NIJMEGEN
postcode: 6532SZ

contact info
Titolo: Dr.
Nome: Johan Willem
Cognome: Mouton
Email: send email
Telefono: +31 24 365 7514
Fax: + 31 24 3657516

NL (NIJMEGEN) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

mechanisms    antibiotic    molecular    saturn    resistant    amr    bacteria    combining    randomized    exposure    effect    impact    clinical    fluoroquinolone    emergence   

 Obiettivo del progetto (Objective)

'Many results drawn from previous studies of the effect of antibiotic use on emergence, selection and spread of antimicrobial resistance (AMR) have lacked a holistic view combining all aspects into one study. The SATURN project aims to study the impact of antibiotic exposure on AMR with a multidisciplinary approach that bridges molecular, epidemiological, clinical and pharmacological research. Two types of clinical studies will be conducted: First, a randomized trial will be performed to resolve an issue of high controversy (antibiotic cycling vs. mixing). Second, 3 observational studies will be conducted to rigorously study issues surrounding the effect of antibiotic use on AMR that are not easily assessable through randomized trials. These clinical studies will serve as a platform to 2 complementary workpackages (microbiology & pharmacology) that will perform important investigations relevant to this call. The work package focusing on molecular studies will generate new evidence about the changes effected by antibiotic therapy on commensal organisms or opportunistic pathogens in the oropharyngeal, nasal and gastro-intestinal flora and study AMR mechanisms and the dissemination of successful clones of fluoroquinolone-resistant, carbapenem-resistant or extended-spectrum beta-lactamase harboring Gram-negative bacteria, MRSA and fluoroquinolone-resistant viridans streptococci. The purpose of the pharmacodynamic study is to model the relationships between antibiotic exposure and AMR emergence over time for various classes of agents. In summary, the overarching rationale of SATURN is to improve methodological standards and conduct research that will help to better understand the impact of antibiotic use on acquisition, selection and transmission of AMR in different environments, by combining analyses of molecular, individual patient-level and ecologic data. The anticipated results may guide clinical and policy decisions to ultimately reduce the burden of AMR in Europe.'

Introduzione (Teaser)

Antibiotic misuse triggers the emergence of drug-resistant bacteria. Understanding the mechanisms underlying this phenomenon should help develop appropriate measures.

Altri progetti dello stesso programma (FP7-HEALTH)

CEPHOS-LINK (2014)

Comparative Effectiveness research on Psychiatric HOSpitalisation by record LINKage of large administrative data sets

Read More  

MEMSTICK (2008)

Synaptic mechanisms of memory loss: novel cell adhesion molecules as therapeutic targets

Read More  

AIDA (2011)

Preserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibiotics

Read More